Apr 13, 2020
Medicure To Announce Fiscal Year End 2019 Financial Results on April 15, 2020
Dec 31, 2019
Early Warning News Release - Dr. Albert D. Friesen Holdings in Medicure Inc.
Dec 20, 2019
Medicure Announces Preliminary Results of Substantial Issuer Bid
Dec 17, 2019
Medicure Announces the Completion of Shortened AGGRASTAT® Versus Integrilin® in Percutaneous Coronary Intervention (SAVI-PCI) Study
Dec 12, 2019
Medicure Announces Completion of Enrollment for FABOLUS-FASTER, Phase 4 Clinical Trial of Aggrastat (Tirofiban Hydrochloride) Injection VS Kengreal (Cangrelor) in Patients Undergoing Percutaneous Coronary Intervention (PCI)
Dec 05, 2019
Medicure Announces Settlement of Holdback Dispute from Apicore Sale
Dec 05, 2019
Medicure Files Patent Infringement Action
Nov 26, 2019
Medicure Reports Financial Results for Quarter Ended September 30, 2019
Nov 19, 2019
Medicure Q3 2019 Results and Conference Call Dates
Nov 13, 2019
Medicure Announces Commencement of Substantial Issuer Bid
Nov 04, 2019
Medicure Announces Intention to Commence Substantial Issuer Bid
Oct 15, 2019
Medicure Announces SMILE(TM)-HF Study Demonstrates Use of ReDS(TM) Results in 58% Reduction in Hospital Readmission Rate
Oct 03, 2019
Medicure Announces Preferred Pricing Agreement for Zypitamag(TM) with the AIDS Drug Assistance Program ("ADAP") Crisis Task Force
Sep 30, 2019
Medicure Announces Acquisition Of Full United States Ownership Of Zypitamag(TM)
Sep 17, 2019
Medicure Announces Launch of New and Improved ReDS(TM) PRO
Aug 21, 2019
Medicure Announces Settlement of Patent Infringement Action
Aug 08, 2019
Medicure Reports Financial Results for Quarter Ended June 30, 2019
Aug 02, 2019
Medicure Q2 2019 Results and Conference Call Dates
Jun 26, 2019
Medicure Announces Results of 2019 Annual Meeting of Shareholders
Jun 10, 2019
Medicure Announces Appoinment of Dr. Neil Owens as President and Chief Operating Officer